Drug Shortage Report for NOZINAN INJ 25MG/ML
Report ID | 152693 |
Drug Identification Number | 01927698 |
Brand name | NOZINAN INJ 25MG/ML |
Common or Proper name | Nozinan |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | METHOTRIMEPRAZINE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 |
ATC code | N05AA |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-01-12 |
Estimated end date | 2022-05-16 |
Actual end date | 2022-05-13 |
Shortage status | Resolved |
Updated date | 2022-05-14 |
Company comments | Lots received are not releasable at this time. Intermittent supply available. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | Yes |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2022-05-14 | English | Compare |
v13 | 2022-05-13 | French | Compare |
v12 | 2022-05-13 | English | Compare |
v11 | 2022-04-11 | French | Compare |
v10 | 2022-04-11 | English | Compare |
v9 | 2022-02-21 | English | Compare |
v8 | 2022-02-04 | French | Compare |
v7 | 2022-02-04 | English | Compare |
v6 | 2022-02-04 | French | Compare |
v5 | 2022-02-04 | English | Compare |
v4 | 2022-02-04 | English | Compare |
v3 | 2022-01-13 | French | Compare |
v2 | 2022-01-13 | English | Compare |
v1 | 2022-01-13 | English | Compare |
Showing 1 to 14 of 14